Table: Kobayashi Pharmaceutical -2017 group results

Kobayashi Pharmaceutical

02/02/2018 11:20

Feb 2 (Reuters)-  
          Kobayashi Pharmaceutical Co Ltd  
          CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                   Year ended      Year ended       Year to       NEXT    
                Dec 31, 2017    Dec 31, 2016   Dec 31, 2018     YEAR      
                   LATEST         YEAR-AGO        COMPANY      COMPANY    
                   RESULTS         RESULTS       FORECAST    H1 FORECAST  
  Sales            156.76          120.05         163.00                  
                                                (+4.0 pct)                
  Operating         22.93           17.41          23.70                  
                                                (+3.4 pct)                
  Recurring         24.19           19.50          24.80                  
                                                (+2.5 pct)                
  Net 
  Net               15.86           14.32          17.00                  
                                                (+7.2 pct)                
  EPS            201.31 yen      179.12 yen     215.33 yen                
  EPS Diluted    201.03 yen      178.86 yen                               
  Ann Div         58.00 yen       52.00 yen      60.00 yen                
  -Q2 Div         28.00 yen       25.00 yen      30.00 yen                
  -Q4 Div         30.00 yen       27.00 yen      30.00 yen                
   
  NOTE - Kobayashi Pharmaceutical Co Ltd. 
  *Second Net profit row denotes profit attributable to owners ofthe parent  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T 
  ((Tokyo Headline News Desk +813 6441 1812))